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Introduction
Today, many options are available for patients with a
small, localized renal tumor. Open partial nephrectomy
provides excellent oncologic and renal functional out-
comes at more than 10 years.1 Since the first laparo-
scopic nephrectomy for benign kidney disease was
performed in 1991 by Clayman et al,2 laparoscopy
has gained wide acceptance by urologists. For the last
6–7 years, many surgeons have begun developing lap-
aroscopic partial nephrectomy (LPN). LPN is a tech-
nically challenging procedure with a steep learning
curve. Initially, the renal tumors were limited to smaller
tumors peripherally located and protruding from the
surface. However, improvements in technique, equip-
ment and accumulation of experience have allowed
successful LPNs on larger centrally located tumors 
or even tumors in close proximity to hilar vessels. 
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We present our interim results of LPN with its com-
plications and outcomes.
Methods
A total of 46 LPNs were performed in 45 patients at
Taipei Veterans General Hospital between April 2004
and September 2008. The procedure was performed
for 45 renal masses in 44 patients. One patient who
had bilateral renal masses underwent LPN twice. One
patient received LPN due to duplication of the left
collecting system. All of the research conformed to
the Declaration of Helsinki’s ethical principles for med-
ical research involving human subjects. We prospec-
tively collected preoperative baseline demographic data
and perioperative data. Missing data were gathered
from the medical records retrospectively. The patient
characteristics are summarized in Table 1. All the
patients underwent preoperative contrast-enhanced
computed tomography (CT) with 3-dimensional vol-
ume reconstruction to evaluate tumor location, depth
of invasion, proximity to the renal sinus or hilum and
vascular anatomy. Most CT imaging studies were per-
formed within our hospital according to the standard
protocol for renal masses. Maximal tumor diameter
was calculated on the preoperative CT images. A deep
tumor was defined as the distance between the tumor
and renal sinus being less than 5 mm on preoperative
CT images. Preoperative serum creatinine was collected.
All patients underwent comprehensive renal function
studies to evaluate the separate renal function of both
kidneys. Body mass index (BMI) was determined by the
World Health Organization classification for BMI.
The anesthesia risks were determined by the American
Society of Anesthesiologists (ASA) Physical Status
Classification.
All surgery was recorded digitally. The operative
procedures were similar to those of reported LPN
series. Briefly, the transperitoneal approach was used
for all cases. The hilar vessels and the kidney were dis-
sected from the surrounding tissues while preserving
the perirenal fat covering the tumor. Intraoperative
ultrasonography was applied to locate the tumor and
assess its size and depth, and whether any undetected
satellite tumors were present. The hilar vessels were
then clamped with laparoscopic bulldog clamps when
needed. The renal arteries were clamped first, and then
the renal veins were clamped if obvious bleeding was
found while excising the tumor. Subsequently, the tu-
mor was excised using cold scissors, which allowed clear
visualization of the normal tissue, and thereby ensured
an adequate safe margin. A frozen section of the tumor
base was checked only in uncertain cases. The opened
collecting system was repaired by intracorporeal free-
hand suturing. Hemostasis was achieved by using argon
beam coagulation, fibrin sealant, and bolster sutures.
The perioperative data were recorded, including
intraoperative sonography, hilar vessel clamping, warm
ischemic time, collecting system violation, operative
time, estimated blood loss, postoperative hospital stay,
and complications. The major complications were de-
fined as urine leakage and/or bleeding requiring inter-
vention. The cancer staging was according to the
American Joint Committee on Cancer (AJCC) Cancer
Staging Manual, 6th edition. The follow-up surveillance
protocol comprised radiographic evaluation consisting
of a CT scan of the kidney and chest, whole-body bone
scan, as well as serum creatinine and comprehensive
renal function studies in the patients diagnosed with
renal cell carcinoma (RCC). All studies except for the
whole-body bone scan were performed every 3 months
in the 1st year, every 6 months in the 2nd year, and yearly
thereafter. The whole-body bone scan was performed
every year or when clinically indicated.
Paired t tests were used to analyze the functional
outcomes. A p value less than 0.05 was considered
significant.
Results
For the 45 patients, mean age was 54.8 ± 15.9 years
(range, 26–85 years). Mean BMI was 25.5 ± 3.8 and
mean ASA was 2.1 ± 0.5. Thirty-one (68.9%) patients
Table 1. Demographic data of 44 patients*
Age (yr) 54.8 ± 15.9
Mean body mass index (kg/m2) 25.5 ± 3.8
ASA 2.1 ± 0.5
Male 30 (68.2)
Left side/right side 24 (53.3)/21 (46.7)
Upper pole 9 (20.0)
Upper and middle interpolar 2 (4.4)
Middle pole 19 (42.2)
Middle and lower interpolar 6 (13.3)
Lower pole 9 (20.0)
Solitary kidneys 2 (4.5)
Tumor diameter (cm) 3.7 ± 1.4
Deep tumors 30 (68.2)
Intraoperative ultrasonographies 34 (79.1)
Endophytic tumors 3 (6.7)
< 50% exophytic tumors 19 (42.2)
> 50% exophytic tumors 24 (53.3)
*Data presented as mean ± standard deviation or n (%). ASA = American
Society of Anesthesiologists Physical Status Classification.
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were male and 14 (31.1%) were female. Of the 46 LPNs,
there were 45 LPNs for renal tumors and 1 LPN for
duplication of the left collecting system. There were
24 (53.3%) tumors in the left kidneys and 21 (46.7%)
tumors in the right kidneys. There were 2 (4.4%) tumors
in the solitary kidneys. One patient had bilateral renal
tumors. Mean tumor maximal diameter on preopera-
tive CT images was 3.7 ± 1.4 cm (range, 2.0–7.5 cm).
Thirty (68.2%) tumors were deep tumors.
Of these procedures, 3 (6.5%) LPNs were converted
to laparoscopic radical nephrectomy. Two (4.3%) of
them were due to a positive margin revealed by frozen
section. The other LPN was converted due to ST
depression just before tumor excision. These LPNs
were excluded from the analysis. The perioperative data
of the remaining 43 LPNs in 42 patients are summa-
rized in Table 2. All patients underwent the transperi-
toneal approach. There was no open conversion. The
mean operative time was 319.0 ± 87.3 minutes (range,
180–660 minutes). Laparoscopic sonography was used
in 34 (79.1%) LPNs. There were 37 (86%) LPNs that
needed hilar vessel clamping, and the mean warm
ischemic time was 55.8 ± 17.5 minutes. Twenty-five
(58.1%) LPNs had collecting system violation that
needed repair. The mean estimated blood loss was
500.5 ± 589.9 mL (range, 20–3,300 mL), and 7 LPNs
had a blood transfusion during the operation. The mean
postoperative hospital stay was 6.9 ± 3.2 days. The
reoperation rate was zero. There were 2 (4.3%) major
complications. One patient suffered from bleeding 1
month postoperatively, and she therefore received an-
giographic embolization of the bleeding vessel. One
patient experienced urinary extravasation requiring
double-J stenting.
Pathological analysis of the 43 tumors showed 17
(39.5%) benign tumors, with angiomyolipoma (AML)
in 12 (27.9%) and other benign tumors in 5 (11.6%), 26
(60.5%) RCC including clear cell RCC in 23 (53.5%),
papillary RCC in 1 (2.3%), and chromophobe RCC in
2 (4.7%) (Table 3). In the 12 patients with AML, the
indications for LPN were a large sized tumor in 6 pa-
tients, suspected RCC in 4 patients, and symptomatic
AML in 2 patients. Surgical margins of malignant tumors
were all negative. The pathological stages were pT1a
in 19 (73.1%) patients, pT1b in 5 (19.2%) patients, pT2
in 1 (3.8%) patient, and pT3a in 1 (3.8%) patient.
During the follow-up (range, 7–62 months; mean,
21.2 months), 1 patient had bleeding 1 month after
surgery. The remaining 41 patients had no complica-
tions. There were 26 patients with RCC. During a
mean follow-up of 27.7 months (range, 7–56 months),
local recurrence of RCC was found in 1 patient. The
tumor size was 1.5 × 1.0 × 0.8 cm. During the opera-
tion, intraoperative sonography and frozen sectioning
were not performed. The pathological report showed
a tumor-free margin. Radiofrequency ablation was used
for the recurrent tumor. No patients had distant metas-
tasis. There was no mortality. The mean preoperative
creatinine was 1.04 mg/dL (range, 0.6–2.4 mg/dL).
The mean elevated creatinine level was 0.10 mg/dL at
postoperative month 3 (p < 0.05), 0.13 mg/dL at post-
operative month 6 (p < 0.05), and 0.13 mg/dL at post-
operative month 12 (p < 0.05) (Figure 1). The effective
renal plasma flow of the operated kidney was reduced by
a mean of 21.9% at 3 months postoperatively (p<0.05),
27.7% at 6 months postoperatively (p<0.05), and 23.0%
at 12 months postoperatively (p < 0.05; Figure 2).
Table 2. Perioperative data*
Transperitoneal approaches 43 (100)
Intraoperative ultrasonographies 34 (79.1)
Hilar vessel clamps 37 (86.0)
Warm ischemic time (min) 55.8 ± 17.5
Collecting system violations 25 (58.1)
Operative time (min) 319.0 ± 87.3
Estimated blood loss (mL) 500.5 ± 589.9
Blood transfusions 7 (16.3)
Postoperative hospital stay (d) 6.9 ± 3.2
*Data presented as n (%) or mean ± standard deviation.
Table 3. Pathological data*
Benign 17 AML 12
JG cell tumor 1
Duplication 1
Capsular leiomyoma 1
Oncocytoma 1
Metanephric adenoma 1
Malignant 26 Clear cell RCC 23
Papillary RCC 1
Chromophobe RCC 2
*Data presented as n. AML = angiomyolipoma; JG = juxtaglomerular cell tumor;
RCC = renal cell carcinoma.
0.0
0.5
1.0
1.5
2.0
2.5
3.0
3.5
4.0
4.5
C
re
at
in
in
e 
(m
g/
dL
)
Pre-op 3 mo
post-op
6 mo
post-op
9 mo
post-op
12 mo
post-op
15 mo
post-op
Figure 1. Postoperative serum creatinine levels.
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Discussion
Robson first reported radical nephrectomy in 1963.3
Radical nephrectomy has been the standard treatment
for renal tumors. In recent years, some surgeons have
investigated nephron-sparing surgery for solitary kidney
or small sized renal tumors. Open partial nephrectomy
provides excellent oncologic and functional outcomes.4
Open partial nephrectomy also demonstrates similar
outcomes compared with radical nephrectomy.5,6
Clayman et al2 performed the first laparoscopic nephrec-
tomy for benign kidney disease in 1991 and the first
LPN was reported in 1993.7,8 However, LPN is a skill-
challenging surgery. Reports of its long-term onco-
logic outcomes are limited. Some short-term survival
evaluations have been reported. LPN is an alternative
technique with mid-term oncologic results compara-
ble to those for open partial nephrectomy.9–11
In this study, we presented our experience with
LPN. The mean operative time was 319 minutes and
the mean blood loss was 501 mL. Pedicle clamping was
performed in 37 cases and the mean warm ischemic
time was 56 minutes. Three patients were converted
to laparoscopic radical nephrectomy. No patient was
converted to the open method. No patient had a pos-
itive surgical margin. Ramani et al12 reported 200
LPNs with a mean operative time of 199 minutes,
mean blood loss of 247 mL, mean ischemic time of
28.7 minutes, and 2 LPNs that were converted to the
open method. Venkatesh et al13 reported 123 LPNs
with a mean operative time of 204 minutes, mean blood
loss of 269 mL, and 2 LPNs that were converted to
laparoscopic radical nephrectomy. Permpongkosol 
et al9 reported 143 LPNs with pathological stage pT1a.
In their study, the mean operative time was 225.18
minutes, mean estimated blood loss was 436.9 mL,
and mean ischemic time was 29.5 minutes. The sur-
gical margins were positive in 2 (2.35%) patients.
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Figure 2. Postoperative effective renal plasma flow (ERPF).
Yoshikawa et al14 reported 17 patients who were
treated with LPN. One required conversion to open
surgery because of uncontrollable bleeding. The mean
operative time was 270 minutes and mean estimated
bleeding volume was 301 mL. The mean ischemic time
was 25 minutes. A longer operative time and ischemic
time, and larger volume of estimated blood loss were
found in our study compared with these previous stud-
ies. A greater tumor size, higher BMI, and central tu-
mor location are associated with a longer warm ischemic
time.15 In our study, the mean tumor size (3.7 cm)
was relatively larger than that in the previous studies
mentioned above (2.5 cm,14 2.6 cm,13 and 2.9 cm12).
The occurrence of deep tumors in our study (68.7%)
was significantly higher than that in Ramani et al’s study
(25%)12 and Venkatesh et al’s study (6.5%).13 These 
2 factors (tumor size and depth) might increase warm
ischemic time. They also influenced the operative time
of our study. The learning curve for performing LPN
probably influenced operative time as well. Our LPN
data were collected since the first LPN was performed
at our hospital. Gill et al16 presented 800 consecutive
LPNs of a single surgeon’s series. A longer warm is-
chemic time was found in the first 34.5% of LPNs.
Therefore, the surgeon’s experience might also be a
predictor of prolonged warm ischemia time. This was
also our interim experience of LPN. The technique of
LPN is still evolving. Our conversion rate to laparo-
scopic radical nephrectomy or the open method did not
appear to be different from those of previous studies.
Our major complication rate was 4.3%. There was
delayed bleeding in 1 patient and urine leakage in 1
patient. Ramani et al12 reported hemorrhage in 19
(9.5%) patients and urine leakage in 9 (4.5%) patients.
Permpongkosol et al9 reported a major complication
rate of 5.8%. Simon et al17 presented the Mayo clinic
experience, with a major complication rate of 5.6%.
Our complication rate is similar to that of these other
studies. The learning curve of LPN did not increase the
complication rate. Our surgical techniques of LPN were
favorable. Embolization was performed in the patient
with delayed bleeding. The patient with urine leakage
received a double-J stent. The management of com-
plications was similar to that in other studies.
With regard to functional outcomes, our study
showed elevated postoperative serum creatinine levels
and decreased effective renal plasma flow in the oper-
ated kidneys. Lane and Gill18 reported that no patients
with normal baseline serum creatinine undergoing
elective LPN had postoperative chronic renal insuffi-
ciency. Bhayani et al19 showed that based on postoper-
ative serum creatinine levels, warm ischemic time up
to 55 minutes did not significantly influence long-term
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renal function after LPN. Although our mean warm
ischemic time was 56 minutes, we found an elevation
of serum creatinine levels. The normal tissue of the
operated kidney was also partially excised. A slight
loss of renal function would be predicted. During the
follow-up, serum creatinine levels and effective renal
plasma flow showed no significant change between
postoperative month 3 and month 6 (p>0.05), and be-
tween postoperative month 3 and month 12 (p > 0.05).
The renal function of the operated kidney was stabi-
lized from postoperative month 3 in our study. The
warm ischemic time did not result in a prolonged
influence on renal function.
There were several limitations to this study. The
first limitation was the retrospective nature of the data
analysis. All data were collected into our database
prospectively. Second, the number of patients was rel-
atively fewer than in other studies. Patients within the
learning curve of LPN were also enrolled in our study.
However, this data reflects the learning experience of a
single surgeon. Third, this study presented only interim
oncologic and functional outcomes. Longer follow-up
data of oncologic outcomes are needed.
In conclusion, the technique of LPN is still evolv-
ing. Although our warm ischemic time and operative
time were longer than those of other LPN studies, the
interim results of our oncologic and functional out-
comes were encouraging. Further refinement of the
operative procedures is needed to shorten the warm
ischemic time. Additionally, based on postoperative
renal function, LPN does not significantly influence
long-term renal function.
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